Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination
出版年份 2016 全文链接
标题
Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination
作者
关键词
-
出版物
MEDIATORS OF INFLAMMATION
Volume 2016, Issue -, Pages 1-12
出版商
Hindawi Limited
发表日期
2016-02-12
DOI
10.1155/2016/5740373
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Increased Tumor-Specific CD8+ T Cell Induction by Dendritic Cells Matured with a Clinical Grade TLR-Agonist in Combination with IFN-γ
- (2017) J. Vanderlocht et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
- (2015) Dalil Hannani et al. CELL RESEARCH
- The transduction pattern of IL-12-encoding lentiviral vectors shapes the immunological outcome
- (2015) Cleo Goyvaerts et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β
- (2015) Dhifaf Sarhan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists
- (2015) Martin Kreutz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Potency of Both Human Th1 and NK Helper Cell Activation is Determined by IL-12p70-Producing PAMP-Matured DCs
- (2015) Tammy Oth et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Toxicity Patterns With Immunomodulating Antibodies and Their Combinations
- (2015) John B.A.G. Haanen et al. SEMINARS IN ONCOLOGY
- An optimized peptide vaccine strategy capable of inducing multivalent CD8+T cell responses with potent antitumor effects
- (2015) Hyun-Il Cho et al. OncoImmunology
- Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases
- (2014) Sofie Wilgenhof et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Natural Killer Cells: The Secret Weapon in Dendritic Cell Vaccination Strategies
- (2014) Catharina H.M.J. Van Elssen et al. CLINICAL CANCER RESEARCH
- Dendritic Cell Cross Talk with Innate and Innate-like Effector Cells in Antitumor Immunity: Implications for DC Vaccination
- (2014) Jasper J. P. van Beek et al. CRITICAL REVIEWS IN IMMUNOLOGY
- The immune contexture of primary and metastatic human tumours
- (2014) Nicolas A Giraldo et al. CURRENT OPINION IN IMMUNOLOGY
- Cancer vaccine adjuvants – recent clinical progress and future perspectives
- (2014) Abid H. Banday et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Specific CD4+ T Cells Render the Tumor Environment Permissive for Infiltration by Low-Avidity CD8+ T Cells
- (2014) S. B. J. Wong et al. JOURNAL OF IMMUNOLOGY
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Monitoring the Initiation and Kinetics of Human Dendritic Cell-Induced Polarization of Autologous Naive CD4+ T Cells
- (2014) Tammy Oth et al. PLoS One
- IL-18-Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment
- (2013) J. L. Wong et al. CANCER RESEARCH
- Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells
- (2013) J. Goc et al. CANCER RESEARCH
- Turning Tumors into Vaccines: Co-opting the Innate Immune System
- (2013) Jasper G. van den Boorn et al. IMMUNITY
- IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity
- (2013) Beatriz M. Carreno et al. JOURNAL OF CLINICAL INVESTIGATION
- TLR agonists: our best frenemy in cancer immunotherapy
- (2013) Sabina Kaczanowska et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Toll-Like Receptor 4 Engagement Drives Differentiation of Human and Murine Dendritic Cells from a Pro- into an Anti-Inflammatory Mode
- (2013) Romana Luger et al. PLoS One
- Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
- (2013) D. Sugiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases
- (2012) Arcadi Cipponi et al. CANCER RESEARCH
- Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I-Modified Peptides
- (2012) P. Filipazzi et al. CLINICAL CANCER RESEARCH
- Tumor-Infiltrating FoxP3+ Tregs and CD8+ T Cells Affect the Prognosis of Hepatocellular Carcinoma Patients
- (2012) Yong Huang et al. DIGESTION
- Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer
- (2012) Alexander Pedroza-Gonzalez et al. HEPATOLOGY
- Cancer classification using the Immunoscore: a worldwide task force
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
- (2012) Ravi A Madan et al. LANCET ONCOLOGY
- Combined Tbet and IL12 Gene Therapy Elicits and Recruits Superior Antitumor Immunity In Vivo
- (2012) Yanyan Qu et al. MOLECULAR THERAPY
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- NK Cells: Key to Success of DC-Based Cancer Vaccines?
- (2012) E. Lion et al. ONCOLOGIST
- Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLs
- (2012) Erik Berk et al. VACCINE
- Lymphocyte-polarized DC1s
- (2012) Erik Berk et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Inflammation restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation
- (2011) C. H. M. J. Van Elssen et al. BLOOD
- Generation of immunogenic and tolerogenic clinical-grade dendritic cells
- (2011) Tahereh Kalantari et al. IMMUNOLOGIC RESEARCH
- Helper Activity of Natural Killer Cells During the Dendritic Cell-mediated Induction of Melanoma-specific Cytotoxic T Cells
- (2011) Jeffrey L. Wong et al. JOURNAL OF IMMUNOTHERAPY
- Engineering Dendritic Cells to Enhance Cancer Immunotherapy
- (2011) Jeanette E Boudreau et al. MOLECULAR THERAPY
- Tumour-loaded α-type 1-polarized Dendritic Cells from Patients with Chronic Lymphocytic Leukaemia Produce a Superior NK-, NKT- and CD8+ T Cell-attracting Chemokine Profile
- (2011) Karin Gustafsson et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15
- (2010) L. Vujanovic et al. BLOOD
- PGE2 transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells
- (2010) R. Muthuswamy et al. BLOOD
- Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy
- (2010) Gerty Schreibelt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
- (2010) R. Bos et al. CANCER RESEARCH
- Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
- (2010) J. Mitsui et al. CLINICAL CANCER RESEARCH
- Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
- (2010) J. F. M. Jacobs et al. CLINICAL CANCER RESEARCH
- Klebsiella pneumoniae-triggered DC recruit human NK cells in a CCR5-dependent manner leading to increased CCL19-responsiveness and activation of NK cells
- (2010) Catharina H. M. J. Van Elssen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity
- (2010) Simon S Jensen et al. Journal of Inflammation-London
- Evaluation of natural killer cell defense in oral squamous cell carcinoma
- (2010) Mahiye Reyhan Türkseven et al. ORAL ONCOLOGY
- Polarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors
- (2010) Pawel Kalinski et al. SEMINARS IN IMMUNOLOGY
- Dendritic Cell-Based Cancer Gene Therapy
- (2009) Evelien L.J.M. Smits et al. HUMAN GENE THERAPY
- NK cells enhance the induction of CTL responses by IL-15 monocyte-derived dendritic cells
- (2009) Melinda Y Hardy et al. IMMUNOLOGY AND CELL BIOLOGY
- Toll-like receptor agonists in cancer therapy
- (2009) Sylvia Adams Immunotherapy
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
- (2009) Franck Pagès et al. JOURNAL OF CLINICAL ONCOLOGY
- Dendritic cells require a systemic type I interferon response to mature and induce CD4+Th1 immunity with poly IC as adjuvant
- (2009) M. Paula Longhi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Ectopic T-bet Expression Licenses Dendritic Cells for IL-12-Independent Priming of Type 1 T Cells In Vitro
- (2009) M. W. Lipscomb et al. JOURNAL OF IMMUNOLOGY
- Independent Regulation of Chemokine Responsiveness and Cytolytic Function versus CD8+ T Cell Expansion by Dendritic Cells
- (2009) P. B. Watchmaker et al. JOURNAL OF IMMUNOLOGY
- Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties
- (2009) Sébastien Anguille et al. Journal of Translational Medicine
- CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help
- (2009) Yusuke Nakanishi et al. NATURE
- TLR expression and NK cell activation after human yellow fever vaccination
- (2009) Patrícia Cristina da Costa Neves et al. VACCINE
- Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
- (2008) Paolo Carrega et al. CANCER
- Recruitment and Activation of Natural Killer Cells In vitro by a Human Dendritic Cell Vaccine
- (2008) K. Gustafsson et al. CANCER RESEARCH
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
- (2008) Lun Cai et al. CLINICAL IMMUNOLOGY
- Paradigm Shifts in Cancer Vaccine Therapy
- (2008) Jeffrey Schlom et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
- (2008) Joseph D. Miller et al. IMMUNITY
- Toll-like Receptors Activate Innate and Adaptive Immunity by using Dendritic Cell-Intrinsic and -Extrinsic Mechanisms
- (2008) Baidong Hou et al. IMMUNITY
- Dendritic Cells In Vivo: A Key Target for a New Vaccine Science
- (2008) Ralph M. Steinman IMMUNITY
- Inflammatory signals in dendritic cell activation and the induction of adaptive immunity
- (2008) Olivier Joffre et al. IMMUNOLOGICAL REVIEWS
- CD40 ligation restores type 1 polarizing capacity in TLR4-activated dendritic cells that have ceased interleukin-12 expression
- (2008) Alexander Michael Dohnal et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines
- (2008) Alexander Michael Dohnal et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- IL-15Rα chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation
- (2008) Erwan Mortier et al. JOURNAL OF EXPERIMENTAL MEDICINE
- OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
- (2008) Silvia Piconese et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine
- (2008) C. Trumpfheller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sipuleucel-T: A Vaccine for Metastatic, Asymptomatic, Androgen-Independent Prostate Cancer
- (2007) Punam H Patel et al. ANNALS OF PHARMACOTHERAPY
- Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer
- (2007) G. Esendagli et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now